BioXcel Therapeutics, Inc. (BTAI)
Confidential investigation: officers & directors’ potential breach of fiduciary duties to investors.
Investigation
01/20/2021
Initial Lawsuit
01/20/2021
Lawsuit Progression
04/29/2021
Investigation regarding Bit Digital’s statements about its crypto currency business, notably the company’s number of miners and aggregate mining equipment.
01/11/2021
Short-seller firm J Capital Research publishes a report alleging overstatement of Bit Digital’s mining operations, fraudulent bitcoin mining operations and fake purchases, partly causing the stock price to decrease 25% to close at $18.76 per share.
Stock Impact
Close | Previous close | Price variation | Percentage variation |
---|---|---|---|
$18.76 | $25.03 | $-6.27 | -25.05% |
Plaintiff brings this securities class action on behalf of persons and entities that purchased or otherwise acquired Bit Digital securities between December 21, 2020 and January 8, 2021, inclusive.
According to the complaint, defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the company’s business, operations, and prospects. Specifically, defendants allegedly failed to disclose to investors:
(i) that Bit Digital overstated the extent of its a bitcoin mining operation;
(ii) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
04/29/2021
The court issued an order appointing the lead plaintiff and lead counsel.
07/06/2021
Lead plaintiff brings this securities class action brought on behalf of all investors who purchased or otherwise acquired Bit Digital, Inc. common stock between December 21, 2020 and January 11, 2021, inclusive.
Operative complaint
11/19/2021
A motion to dismiss was filed with the court.
Confidential investigation: officers & directors’ potential breach of fiduciary duties to investors.